Literature DB >> 19817884

Adherence to acute migraine medication: what does it mean, why does it matter?

Bozena J Katić1, Steven J Krause, Stewart J Tepper, Henry X Hu, Marcelo E Bigal.   

Abstract

Proper use of medications is an important part of successfully managing migraine headache, yet migraineurs frequently switch, discontinue, or delay taking effective prescription therapies such as triptans. Medication persistence in the treatment of chronic-episodic disorders such as migraine is not well understood. In this article we review this topic, by critically reviewing studies conducted using pharmacy claims, clinical records, survey, and patient-reported data to explore acute medication use for migraine headache. While efficacy, cost, drug tolerability, and side effects impact whether a patient takes migraine medication, low perceived disease importance and factors related to the patient's internal decision-making process play a strong role in the sustained use of acute medication for migraine attack. We propose a model that combines the patient's perceived severity of migraine, their beliefs regarding the safety of acute medications, and factors related to the physician-patient relationship to identify migraineurs at high risk for medication adherence problems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19817884     DOI: 10.1111/j.1526-4610.2009.01535.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  12 in total

1.  Development of a measure of self-efficacy for acute headache medication adherence.

Authors:  Elizabeth K Seng; Robert A Nicholson; Kenneth A Holroyd
Journal:  J Behav Med       Date:  2015-09-24

Review 2.  Improving medication adherence in migraine treatment.

Authors:  Elizabeth K Seng; Jeanetta A Rains; Robert A Nicholson; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2015-06

Review 3.  What the pharmacological management of migraine can tell us about the future of migraine patient care.

Authors:  Paul B Rizzoli
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

4.  Migraine in health workers: working in a hospital can be considered an advantage?

Authors:  M Bartolini; G Viticchi; L Falsetti; A Ulissi; M Baldassari; A Medori; S Mattioli; F Lombardi; L Provinciali; M Silvestrini
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

5.  Psychological evaluation of a primary headache patient.

Authors:  Dana P Turner; Timothy T Houle
Journal:  Pain Manag       Date:  2013-01-01

6.  Instrumental investigations and migraine diagnosis.

Authors:  Giovanna Viticchi; M Bartolini; L Falsetti; R Cerqua; C Lanciotti; L Provinciali; M Silvestrini
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

Review 7.  Disability and quality of life in headache: where we are now and where we are heading.

Authors:  D D'Amico; L Grazzi; S Usai; M Leonardi; A Raggi
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

8.  Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study.

Authors:  Anna Ferrari; Carlo Baraldi; Manuela Licata; Daniele Vandelli; Filippo Marchesi; Federica Palazzoli; Patrizia Verri; Cecilia Rustichelli; Enrico Giuliani; Enrico Silingardi
Journal:  Eur J Clin Pharmacol       Date:  2016-05-31       Impact factor: 2.953

Review 9.  A systematic review of the psychosocial difficulties relevant to patients with migraine.

Authors:  Alberto Raggi; Ambra Mara Giovannetti; Rui Quintas; Domenico D'Amico; Alarcos Cieza; Carla Sabariego; Jerome Edmound Bickenbach; Matilde Leonardi
Journal:  J Headache Pain       Date:  2012-09-23       Impact factor: 7.277

10.  Holding on to the indispensable medication--a grounded theory on medication use from the perspective of persons with medication overuse headache.

Authors:  Pernilla Jonsson; Annika Jakobsson; Gunnel Hensing; Mattias Linde; Crystal Dea Moore; Tove Hedenrud
Journal:  J Headache Pain       Date:  2013-05-22       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.